A randomized, double-blind, non-inferiority study of hydromorphone hydrochloride immediate-release tablets versus oxycodone hydrochloride immediate-release powder for cancer pain: efficacy and safety in Japanese cancer patients

BACKGROUND: Hydromorphone is a standard opioid analgesic for cancer pain that, prior to this study, was not approved in Japan, where options for opioid switching are limited. We aimed to investigate the efficacy and safety of hydromorphone (DS-7113b) immediate-release tablets in opioid-naïve cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Satoshi, Saito, Yoji, Tsuneto, Satoru, Aruga, Etsuko, Takahashi, Hiroshi, Uemori, Mitsutoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5974780/
https://www.ncbi.nlm.nih.gov/pubmed/29659913
http://dx.doi.org/10.1093/jjco/hyy038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5974780/
https://www.ncbi.nlm.nih.gov/pubmed/29659913
http://dx.doi.org/10.1093/jjco/hyy038

Ejemplares similares